DE69714033T2 - Mutierte ras peptide zur zeugung von cd8+ zytitoxischen t lymphoizyten - Google Patents
Mutierte ras peptide zur zeugung von cd8+ zytitoxischen t lymphoizytenInfo
- Publication number
- DE69714033T2 DE69714033T2 DE69714033T DE69714033T DE69714033T2 DE 69714033 T2 DE69714033 T2 DE 69714033T2 DE 69714033 T DE69714033 T DE 69714033T DE 69714033 T DE69714033 T DE 69714033T DE 69714033 T2 DE69714033 T2 DE 69714033T2
- Authority
- DE
- Germany
- Prior art keywords
- ras
- lymphoizytes
- cytitoxic
- muted
- generate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108700042226 ras Genes Proteins 0.000 abstract 2
- 201000009030 Carcinoma Diseases 0.000 abstract 1
- 108020004705 Codon Proteins 0.000 abstract 1
- 102000025850 HLA-A2 Antigen Human genes 0.000 abstract 1
- 108010074032 HLA-A2 Antigen Proteins 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108010014186 ras Proteins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464454—Enzymes
- A61K39/464464—GTPases, e.g. Ras or Rho
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63534496A | 1996-04-19 | 1996-04-19 | |
PCT/US1997/006470 WO1997040156A1 (en) | 1996-04-19 | 1997-04-17 | Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69714033D1 DE69714033D1 (de) | 2002-08-22 |
DE69714033T2 true DE69714033T2 (de) | 2003-02-13 |
Family
ID=24547410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69714033T Expired - Lifetime DE69714033T2 (de) | 1996-04-19 | 1997-04-17 | Mutierte ras peptide zur zeugung von cd8+ zytitoxischen t lymphoizyten |
Country Status (8)
Country | Link |
---|---|
US (1) | US8883448B2 (de) |
EP (1) | EP0895538B1 (de) |
AT (1) | ATE220718T1 (de) |
AU (1) | AU2734397A (de) |
DE (1) | DE69714033T2 (de) |
DK (1) | DK0895538T3 (de) |
ES (1) | ES2180045T3 (de) |
WO (1) | WO1997040156A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7019112B1 (en) | 1996-03-19 | 2006-03-28 | University Of Virginia Patent Foundation | Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor |
EP0966480A2 (de) | 1997-01-30 | 1999-12-29 | The University Of Virginia Patent Foundation | Cystein-reduzierte peptide, welche durch a3-limitierte zytotoxische lymphozyten erkannt werden, sowie anwendungen |
GB2328689A (en) * | 1997-08-27 | 1999-03-03 | Norsk Hydro As | Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer |
GB9907860D0 (en) * | 1999-04-07 | 1999-06-02 | Smithkline Beecham Biolog | Novel compounds |
NO309798B1 (no) * | 1999-04-30 | 2001-04-02 | Targovax As | Peptidblanding, samt farmasoytisk sammensetning og kreftvaksine som innbefatter peptidblandingen |
US8343502B2 (en) | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
EP1581174B1 (de) | 2002-12-16 | 2018-04-25 | GlobeImmune, Inc. | Impfstoffe auf hefebasis als immuntherapie |
CN105999250B (zh) * | 2011-05-24 | 2020-03-10 | 生物技术Rna制药有限公司 | 用于癌症的个体化疫苗 |
WO2013167136A1 (en) | 2012-05-08 | 2013-11-14 | Herlev Hospital | Improving adoptive cell therapy with interferon gamma |
WO2014082729A1 (en) | 2012-11-28 | 2014-06-05 | Biontech Ag | Individualized vaccines for cancer |
WO2015123532A1 (en) * | 2014-02-16 | 2015-08-20 | Globeimmune, Inc. | Ras g12r immunotherapy for ras mutation-positive cancers |
EP3201321A1 (de) * | 2014-10-02 | 2017-08-09 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Verfahren zur isolierung von t-zellen mit antigenspezifizität gegen eine krebsspezifische mutation |
AU2019226586A1 (en) * | 2018-03-02 | 2020-10-15 | Elicio Therapeutics, Inc. | Compounds including a mutant KRAS sequence and a lipid and uses thereof |
CN113631172A (zh) * | 2019-01-25 | 2021-11-09 | 宾夕法尼亚大学理事会 | 用于靶向突变型ras的组合物和方法 |
US20220175899A1 (en) * | 2019-04-11 | 2022-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6039948A (en) | 1973-05-07 | 2000-03-21 | The Ohio State University | Method for treatment of antigenically modified polypeptides |
US5643565A (en) | 1985-09-20 | 1997-07-01 | Chiron Corporation | Human IL-2 as a vaccine adjuvant |
EP0399001B1 (de) | 1988-02-01 | 1994-07-27 | Praxis Biologics, Inc. | T-zellen-epitope als träger für einen konjugierten impfstoff |
GB8924438D0 (en) | 1989-10-31 | 1989-12-20 | Hoffmann La Roche | Vaccine composition |
GB9103974D0 (en) | 1991-02-26 | 1991-04-10 | Norsk Hydro As | Therapeutically useful peptides or peptide fragments |
US5861372A (en) | 1996-02-22 | 1999-01-19 | The Children's Medical Center Corporation | Aggregate angiostatin and method of use |
-
1997
- 1997-04-17 EP EP97921247A patent/EP0895538B1/de not_active Expired - Lifetime
- 1997-04-17 ES ES97921247T patent/ES2180045T3/es not_active Expired - Lifetime
- 1997-04-17 DK DK97921247T patent/DK0895538T3/da active
- 1997-04-17 AT AT97921247T patent/ATE220718T1/de not_active IP Right Cessation
- 1997-04-17 AU AU27343/97A patent/AU2734397A/en not_active Abandoned
- 1997-04-17 WO PCT/US1997/006470 patent/WO1997040156A1/en active IP Right Grant
- 1997-04-17 DE DE69714033T patent/DE69714033T2/de not_active Expired - Lifetime
-
2009
- 2009-11-20 US US12/623,062 patent/US8883448B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2180045T3 (es) | 2003-02-01 |
WO1997040156A1 (en) | 1997-10-30 |
EP0895538A1 (de) | 1999-02-10 |
AU2734397A (en) | 1997-11-12 |
DE69714033D1 (de) | 2002-08-22 |
DK0895538T3 (da) | 2002-11-04 |
US8883448B2 (en) | 2014-11-11 |
EP0895538B1 (de) | 2002-07-17 |
US20100074945A1 (en) | 2010-03-25 |
ATE220718T1 (de) | 2002-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69714033T2 (de) | Mutierte ras peptide zur zeugung von cd8+ zytitoxischen t lymphoizyten | |
CY1107706T1 (el) | Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea) | |
DE69733610D1 (de) | Interleukin-15 antagoniste | |
DE69324487D1 (de) | Rezeptorbindende region des diphtherietoxius | |
AU4072397A (en) | Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor | |
HUP9801826A2 (hu) | HER-2/neu-fehérje intracelluláris doménje, és alkalmazása malignitások megelőzésére és kezelésére | |
NO923953L (no) | Peptider | |
DE59807369D1 (de) | Medizinische Bandage | |
HUP0302532A2 (hu) | Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások | |
ATE217795T1 (de) | Saponin-antigen-konjugate und ihre verwendung | |
DK1210430T3 (da) | MUC-1-afledte peptider | |
IT1196484B (it) | Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe | |
WO1997035021A3 (en) | Prostate specific antigen oligo-epitope peptide | |
DE3764491D1 (de) | Haardauerwellenmittel. | |
UA85365C2 (ru) | Продукт конъюгирования цитокина для использования в противораковой терапии | |
PT1025849E (pt) | Metodos para deteccao e tratamento de individuos tendo celulas anormais que expressam antigenios do peptideo hla-a2/tirosinase | |
NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
BR0110577A (pt) | Decorina transgenicamente produzida | |
FR2804027B1 (fr) | Utilisation d'anticorps monoclonaux anti-ferritines dans le traitement de certains cancers | |
DE3860354D1 (de) | Neigungseinstell- und verstellvorrichtung fuer klapp-, lehnstuehle und aehnliche gegenstaende. | |
EP0836480A4 (de) | Zusammensetzungen, welche adp-ribosyltransferase-aktivität ausweisen und methoden für ihre herstellung und die verwendung derselben | |
BR0107547A (pt) | Receptor | |
DK0952771T3 (da) | Hidtil ukendte saponinpræparater og anvendelser deraf | |
SE9501512D0 (sv) | Synthetic peptide-defined eptopes useful for vaccination against papillomavirus | |
MX9205978A (es) | Nuevas proteinas inhibidoras de trombina de garrapatas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |